Michael P Lisanti Selected Research

Michael P Lisanti Research Topics

Disease

191	Neoplasms (Cancer) 12/2022 - 03/2002
108	Breast Neoplasms (Breast Cancer) 12/2023 - 10/2002
54	Neoplasm Metastasis (Metastasis) 01/2021 - 10/2004
31	Carcinogenesis 10/2017 - 06/2003
22	Prostatic Neoplasms (Prostate Cancer) 11/2016 - 03/2005
15	Infections 03/2020 - 05/2003
15	Inflammation (Inflammations) 10/2015 - 06/2005
14	Mitochondrial Diseases (Mitochondrial Disease) 01/2020 - 01/2006
13	Hypoxia (Hypoxemia) 01/2020 - 04/2010
12	Atherosclerosis 01/2015 - 10/2002
10	Hyperplasia 11/2006 - 10/2002
8	Cardiomyopathies (Cardiomyopathy) 04/2013 - 10/2002
8	Muscular Dystrophies (Muscular Dystrophy) 04/2010 - 01/2002
7	Melanoma (Melanoma, Malignant) 01/2018 - 06/2009
7	Chagas Disease (American Trypanosomiasis) 03/2013 - 09/2004
6	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2020 - 04/2009
5	Fibrosis (Cirrhosis) 07/2013 - 11/2003
5	Starvation 11/2012 - 08/2011
5	Lymphatic Metastasis 04/2012 - 08/2010
4	Disease Progression 01/2021 - 08/2009
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018 - 10/2008
4	Ovarian Neoplasms (Ovarian Cancer) 09/2017 - 01/2012
4	Adenocarcinoma 04/2015 - 11/2006
4	Pulmonary Fibrosis (Fibrosing Alveolitis) 07/2013 - 12/2003
4	Hypertrophy 05/2013 - 08/2006
4	Insulin Resistance 02/2013 - 07/2003
4	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 04/2010 - 10/2003
3	Glioblastoma (Glioblastoma Multiforme) 01/2018 - 05/2013
3	Communicable Diseases (Infectious Diseases) 09/2017 - 08/2013
3	Carcinoma (Carcinomatosis) 01/2017 - 07/2003
3	Necrosis 01/2015 - 03/2007
3	Cardiovascular Diseases (Cardiovascular Disease) 04/2013 - 10/2004

Drug/Important Bio-Agent (IBA)

82	Caveolin 1IBA 01/2021 - 03/2002
57	Proteins (Proteins, Gene)FDA Link 08/2021 - 05/2003
33	Biomarkers (Surrogate Marker)IBA 01/2021 - 06/2002
30	Lactic Acid (Lactate)FDA LinkGeneric 01/2017 - 06/2010
28	Cyclin D1IBA 10/2017 - 05/2003
22	AntioxidantsIBA 01/2021 - 06/2008
20	CaveolinsIBA 01/2021 - 03/2002
20	KetonesIBA 09/2013 - 09/2010
17	Tamoxifen FDA LinkGeneric 12/2023 - 08/2008
15	Adenosine Triphosphate (ATP)IBA 12/2022 - 12/2009
13	EnzymesIBA 12/2017 - 02/2011
12	CholesterolIBA 01/2023 - 10/2002
12	Caveolin 3IBA 01/2015 - 01/2002
11	Doxycycline (Periostat)FDA LinkGeneric 03/2020 - 01/2015
11	Glutamine (L-Glutamine)FDA Link 04/2014 - 09/2010
10	Estrogens (Estrogen)FDA Link 01/2020 - 11/2006
10	CarcinogensIBA 10/2017 - 06/2003
10	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 12/2012 - 08/2011
9	Metformin (Glucophage)FDA LinkGeneric 01/2020 - 04/2011
8	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 06/2005
8	Ketone BodiesIBA 10/2017 - 04/2012
8	LipidsIBA 02/2013 - 03/2002
7	Anti-Bacterial Agents (Antibiotics)IBA 03/2020 - 08/2013
7	Messenger RNA (mRNA)IBA 01/2020 - 07/2003
7	CyclinsIBA 10/2017 - 01/2006
7	Transcription Factors (Transcription Factor)IBA 09/2015 - 05/2003
7	DNA (Deoxyribonucleic Acid)IBA 06/2015 - 05/2003
6	Fatty Acids (Saturated Fatty Acids)IBA 01/2020 - 01/2012
6	Proliferating Cell Nuclear Antigen (PCNA)IBA 09/2017 - 10/2006
6	CytokinesIBA 05/2015 - 07/2009
6	Phosphotransferases (Kinase)IBA 04/2015 - 02/2003
6	LigandsIBA 02/2013 - 06/2005
5	Phenobarbital (Luminal)FDA Link 11/2019 - 07/2004
5	Estrogen ReceptorsIBA 11/2019 - 11/2006
5	AntibodiesIBA 12/2012 - 06/2009
5	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 08/2011 - 05/2003
5	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 04/2010 - 09/2004
4	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2021 - 09/2015
4	Azithromycin (Zithromax)FDA LinkGeneric 03/2020 - 03/2015
4	Interleukin-6 (Interleukin 6)IBA 03/2020 - 07/2012
4	P-2 (P 2)IBA 01/2020 - 09/2017
4	Small Interfering RNA (siRNA)IBA 11/2019 - 06/2010
4	Lipoproteins (Lipoprotein)IBA 12/2014 - 01/2004
4	Insulin (Novolin)FDA Link 03/2013 - 06/2005
4	DystrophinIBA 01/2013 - 10/2003
4	Chloroquine (Aralen)FDA LinkGeneric 12/2012 - 06/2010
4	PoisonsIBA 11/2012 - 04/2011
4	RNA (Ribonucleic Acid)IBA 11/2012 - 06/2002
4	Cyclin-Dependent Kinases (cdk Proteins)IBA 08/2010 - 08/2005
3	bedaquiline (R207910)IBA 01/2021 - 01/2016
3	Mitochondrial Proton-Translocating ATPases (Mitochondrial ATP Synthase)IBA 01/2021 - 01/2016
3	Peptides (Polypeptides)IBA 11/2019 - 08/2006
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2017 - 01/2006
3	SolutionsIBA 09/2017 - 09/2010
3	AndrogensIBA 01/2016 - 08/2010
3	Interleukin-8 (Interleukin 8)IBA 05/2015 - 05/2008
3	ChemokinesIBA 05/2015 - 12/2006
3	InterferonsIBA 05/2015 - 07/2012
3	Therapeutic UsesIBA 03/2015 - 12/2011
3	Extracellular Matrix ProteinsIBA 01/2015 - 09/2003
3	Estrogen Receptor alphaIBA 05/2014 - 06/2006
3	Amino Acids FDA Link 04/2014 - 09/2010
3	CollagenIBA 07/2013 - 05/2005

Therapy/Procedure

72	Therapeutics 01/2021 - 01/2006
12	Drug Therapy (Chemotherapy) 01/2021 - 09/2005
5	Precision Medicine 09/2017 - 04/2011
4	Lasers (Laser) 01/2019 - 06/2006
4	Radiotherapy 01/2013 - 07/2010